Changes of resistance indices after medication in benign prostatic hyperplasia: a prospective study

2003, AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations, J Urol, 170, 530 Park, 2013, Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil, World J Mens Health, 31, 193, 10.5534/wjmh.2013.31.3.193 Welch, 2002, Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study, Urology, 59, 245, 10.1016/S0090-4295(01)01506-0 Yeo, 2016, Korean clinical practice guideline for benign prostatic hyperplasia, Investig Clin Urol, 57, 30, 10.4111/icu.2016.57.1.30 Danish Qaseem, 2016, Prospective evaluation of prostate with transrectal spectral Doppler with biopsy correlation: a clinicopathologic study, Br J Radiol, 89, 10.1259/bjr.20150830 Shinbo, 2011, Application of ultrasonography and the resistive index for evaluating bladder outlet obstruction in patients with benign prostatic hyperplasia, Curr Urol Rep, 12, 255, 10.1007/s11934-011-0189-x Neumaier, 1995, Normal prostate gland: examination with color Doppler US, Radiology, 196, 453, 10.1148/radiology.196.2.7617860 Tsuru, 2005, Resistance index in benign prostatic hyperplasia using power Doppler imaging and clinical outcomes after transurethral vaporization of the prostate, Int J Urol, 12, 264, 10.1111/j.1442-2042.2005.01025.x Ozdemir, 2005, Measuring resistance index in patients with BPH and lower urinary tract symptoms, J Clin Ultrasound, 33, 176, 10.1002/jcu.20115 Fanimi, 2019, Transrectal Doppler Sonography of Benign Prostatic Enlargement in Nigerian Men, J Med Ultrasound, 27, 169 Aldaqadossi, 2012, The value of measuring the prostatic resistive index vs. pressure-flow studies in the diagnosis of bladder outlet obstruction caused by benign prostatic hyperplasia, Arab J Urol, 10, 186, 10.1016/j.aju.2011.12.011 Kwon, 2016, Clinical Significance of the Resistive Index of Prostatic Blood Flow According to Prostate Size in Benign Prostatic Hyperplasia, Int Neurourol J, 20, 75, 10.5213/inj.1630390.195 Wood, 2010, Spectral Doppler signature waveforms in ultrasonography: a review of normal and abnormal waveforms, Ultrasound Q, 26, 83, 10.1097/RUQ.0b013e3181dcbf67 Ozden, 2010, Effect of transurethral resection of prostate on prostatic resistive index, Urol Int, 84, 191, 10.1159/000277597 Bulut, 2015, Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia, Urol Int, 94, 181, 10.1159/000363581 Scofield, 2008, Voiding dysfunction in men: pathophysiology and risk factors, Int J Impot Res, 20, S2, 10.1038/ijir.2008.54 Ng Roehrborn, 2004, Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia, J Urol, 171, 1029 Roehrborn, 2010, The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study, Eur Urol, 57, 123, 10.1016/j.eururo.2009.09.035 Roehrborn, 2002, Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia, Urology, 60, 434, 10.1016/S0090-4295(02)01905-2 Marberger, 1998, Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group, Urology, 51, 677, 10.1016/S0090-4295(98)00094-6 Tsuru, 2002, Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy, Int J Urol, 9, 427, 10.1046/j.1442-2042.2002.00494.x Lechner, 2020, Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors, Eur J Prev Cardiol, 27, 394, 10.1177/2047487319869400 Noh, 2020, Association between lower urinary tract symptoms and cigarette smoking or alcohol drinking, Transl Androl Urol, 9, 312, 10.21037/tau.2020.03.07 Nagakura, 2022, Lifestyle habits to prevent the development of benign prostatic hyperplasia: Analysis of Japanese nationwide datasets, Prostate Int, 10, 200, 10.1016/j.prnil.2022.06.004